An observational study in Emergence Delirium and Post-Operative Cognitive Dysfunction, sponsored by University of Padova. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.
Sponsored by University of Padova · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Emergence Delirium with a site in Italy — 5 open to participants now, 5 under way, none of them phase 3. Emergence Delirium · Italy.
Among the 13 studies in Emergence Delirium with a site in Italy, this one is one of 2 that started in 2019, is one of 7 observational ones, and was the 5th registered.
753 studies on the registry are indexed under Emergence Delirium; 261 are open to participants now.
Browse Emergence Delirium studies →5 of the 13 studies in Emergence Delirium with a site in Italy are open now. Recruiting first, the newest first:
Azienda Ospedaliera Universitaria Integrata Verona · Sites in Italy
Ages 18+
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Sites in Italy
Ages 18–90
Scienceforbrain, UAB · Sites in Italy, United States, Austria and 1 more country
Ages 18–69
Ente Ospedaliero Ospedali Galliera · Sites in Italy
Ages 60+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 141 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 43 (30%) stop at 75 or younger; 33 take children under 18; 24 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 2 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 164 across 278 observational studies indexed under Emergence Delirium.
Median enrollment 90 across the 6 interventional studies, 200 across the 7 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 13 have an industry lead sponsor. The 10 most frequent:
University of Padova is the lead sponsor of 215 studies on the registry; 39 are open to participants now.
University of Padova has 3 studies filed under Emergence Delirium — fewer than ten, so there is no comparison to draw.
3 of the studies in Emergence Delirium with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06761573IRCCS Azienda Ospedaliero-Universitaria di BolognaBilateral Bispectral Index, Asymmetries and Post-operative Delirium | 2026-12 |
| NCT07872982Scienceforbrain, UABBrainProtect-guided, Real-time Cerebral Autoregulation Monitoring and Protection of Brain During Cardiac Surgery With Cardiopulmonary Bypass Requiring Heart-lung Machine | 2027-09-30 |
| NCT03774420University of PadovaPost Operative Cognitive Dysfunction After Oncologic Surgery | 2027-11-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 13 studies in Emergence Delirium with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Aim of this trial is to define if Post-Operative Cognitive Dysfunction, detected analyzing changes between pre-operative and post-operative Neurocognitive Test, and Postoperative Delirium, relate to concentration of effector's site concentration of propofol and remifentanil TCI and to the common intraoperative neuromonitoring values as well as to Pupillometry values (in particular Pupil Diameter, Pupil Latency, and Maximum Contraction Velocity).
Post-Operative Cognitive Dysfunction has not been yet investigated after general anaesthesia with Targeted-Controlled-Infusion (TCI) and Laryngeal-Mask-Airway (LMA), daily used in the investigator's Hospital to anesthetize patients undergoing oncologic surgery (breast, urologic and general surgery). Aim of this trial is to define if neurocognitive tests (Montreal Cognitive Assessment, Trail Making Test A and B, Digit Span Test) before and after surgery, and CAM for Postoperative Delirium relate to concentrations at effector's site (Ce) of propofol and remifentanil TCI and the values of Bispectral Index and Entropy monitoring and Surgical Plethysmographic Index (SPI), as well as to Pupillometry values.
Women and Men subjected to oncologic surgery (breast, urologic general surgery) in general anaesthesia with Laryngeal-Mask-Airway (LMA) anesthetized with propofol and remifentanil delivered by Targeted-Controlled-Infusion (TCI) pumps. Patients will be subjected to neurocognitive tests (MMSE, GEMS, TMT A and B) the day before surgery and before hospital discharge. These test will be related to propofol and remifentanil concentrations at effector site during surgery and awakening, to BIS and Entropia values and to SPI and pupillometry values.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Incidence of Post-Operative Cognitive Dysfunction in oncologic surgery (breast, urolgic and general surgery) patients detected with Global Examination of Mental Test (GEMS)
Discover incidence of Post-Operative Cognitive decline analyzing changes in Post-Operative Cognitive Dysfunction changes between Pre-operative Global Examination of Mental Test (GEMS) test. Better neurocognitve outcome with higher scores)
Time frame: Patients will be subjected to Global Examination of Mental Test (GEMS) test one day before surgery and 1 day after surgery.
Incidence of Post-Operative Cognitive Dysfunction in oncologic surgery (breast, urolgic and general surgery) patients detected with Minimental State Examination (MMSE)
Discover incidence of Post-Operative Cognitive decline analyzing changes in Post-Operative Cognitive Dysfunction changes between Pre-operativeMinimental State Examination (MMSE) test. Better neurocognitve outcome with higher scores)
Time frame: Patients will be subjected to Minimental State Examination (MMSE) test one day before surgery and 1 day after surgery.
Incidence of Post-Operative Cognitive Dysfunction in oncologic surgery (breast, urolgic and general surgery) patients detected with Trail Making Test A and B
Discover Post-Operative Cognitive Dysfunction analyzing changes between Pre-operative Trail Making Test A and B test score and post-operative Trail Making Test A and B test score. These tests will be evaluated in seconds required to be completed (better neurocognitive outcome with fewer seconds required)
Time frame: Patients will be subjected to Trail Making Test (TMT) A and B one day before surgery and 1day after surgery.
Incidence of Post-Operative Delirium in oncologic surgery (breast, urolgic and general surgery) patients
Discover Post-Operative Delirium submitting patients Confusion Assessment Method (CAM) test. Worse neurocognitve outcome with higher scores (ranging from 0 to 4)
Time frame: Patients will be subjected to Confusion Assessment Method (CAM) within 1 hour from awakening from anesthesia .
Incidence of Post-Operative Cognitive Dysfunction in oncologic surgery (breast, urolgic and general surgery) patients
Discover Post-Operative Cognitive Dysfunction analyzing changes between Pre-operative Short Portable Mental Status Questionnaire score and post-operative Short Portable Mental Status Questionnaire test score. Better neurocognitve outcome with higher scores (ranging 0 to 10)
Time frame: Patients will be subjected to Short Portable Mental Status Questionnaire one day before surgery and 1 day after surgery.
Incidence of Post-Operative Cognitive Dysfunction in oncologic surgery (breast, urolgic and general surgery) patients detected with Confusion Assessment Method (CAM)
Discover Post-Operative Cognitive Dysfunction analyzing changes with Confusion Assessment method (CAM). Worse neurocongitive outcome with lower scores.
Time frame: Patients will be subjected to Confusion Assessment Method (CAM) within 1 hour from awakening from anesthesia.
Incidence of Emergence Delirium in oncologic surgery (breast, urolgic and general surgery) patients detected with 4AT test
Discover Post-Operative Cognitive Dysfunction analyzing acute changes in postoperative congition function utilizing the 4AT test. Worse neurocognitve outcome with higher scores. Worse neurocognitve outcome with higher scores
Time frame: Patients will be subjected to 4 AT test within 1 day from awakening from anesthesia .
Started Jul 2019 (actual). Primary completion is estimated for Nov 2027, 100 months after the start.
Of 180 non-industry observational studies under Emergence Delirium, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 100 months is above that.
Counting every sponsor, half of 180 studies reached it within 21 months; a quarter within 10 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.